Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | CDK8 | P49336 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.38 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.38 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | KMO | O15229 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17356332 | 0.98 | KMT2A (0.44) | KMT2ACDK8ALDH1A1HSD17B10HTR2A | |
| SCHEMBL17356328 | 0.98 | KMT2A (0.44) | KMT2ACDK8ALDH1A1HSD17B10HTR2A | |
| SCHEMBL17356326 | 0.97 | KMT2A (0.41) | KMT2ACDK8ALDH1A1HSD17B10HTR2A | |
| SCHEMBL17352167 | 0.94 | MAPT (0.44) | KMT2ACDK8ALDH1A1HSD17B10HTR2A | |
| SCHEMBL17355667 | 0.93 | KMT2A (0.40) | KMT2ACDK8ALDH1A1HSD17B10HTR2A | |
| SCHEMBL17355666 | 0.92 | KMT2A (0.39) | KMT2ACDK8ALDH1A1HSD17B10HTR2A | |
| SCHEMBL17356334 | 0.92 | PPARG (0.45) | KMT2ACDK8HTR2ASLC6A4KCNH2 | |
| SCHEMBL17355813 | 0.92 | KMT2A (0.39) | KMT2ACDK8ALDH1A1HSD17B10HTR2A | |
| SCHEMBL17355669 | 0.92 | KMT2A (0.39) | KMT2ACDK8ALDH1A1HSD17B10HTR2A | |
| SCHEMBL17355816 | 0.91 | KMT2A (0.38) | KMT2AALDH1A1HTR2ASLC6A4KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | UBE INDUSTRIES, LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | UBE INDUSTRIES, LTD. (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150372349-A1 | NON-AQUEOUS ELECTROLYTE AND ELECTRICITY STORAGE DEVICE | HCN2, SCO2, HCN1 | KMT2A 2355/4885CDK8 4065/4885ALDH1A1 1059/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.